What is the appropriate evaluation and management of stomatitis in a patient?

Management of Stomatitis

Begin with basic oral care protocols including sodium bicarbonate mouthwash 4-6 times daily for prevention, and escalate systematically through topical analgesics, topical corticosteroids, and ultimately systemic steroids based on severity and ulcer presence. 1

Initial Evaluation

Determine the underlying etiology and severity:

• Cancer therapy-related: Most common in patients receiving chemotherapy (40% incidence), targeted therapies, or radiation—particularly high-risk in hematologic malignancies and bone marrow transplant (2-3x higher incidence) 2
• Infectious causes: Herpetic stomatitis presents with clustered vesicles that rupture into painful ulcers with lymphadenitis and fever 3
• Uremic stomatitis: Associated with elevated blood urea in chronic kidney disease 4
• Recurrent aphthous stomatitis: Idiopathic or secondary to systemic inflammatory conditions 5

Assess severity by examining:

• Number and location of ulcerations
• Presence of oral dryness
• Pain level (mild, moderate, severe)
• Impact on oral intake and quality of life

Prevention Strategy (For At-Risk Patients)

All patients at risk for therapy-associated stomatitis should implement:

• Basic oral hygiene protocols
• Bland, non-alcoholic sodium bicarbonate mouthwash 4-6 times daily 1
• For high-dose chemotherapy conditioning in hematopoietic cell transplant: Consider low-level laser therapy (Level II evidence) 1

Treatment Algorithm

Step 1: Mild Stomatitis (No or Minimal Ulceration)

• Increase sodium bicarbonate mouthwash frequency up to hourly 1
• For oral dryness: Sugarless chewing gum, candy, salivary substitutes, or sialogogues 1
• Topical anesthetics: Viscous lidocaine 2% mouthwash before painful activities 1
• Coating agents as needed 1

Step 2: Moderate Pain with Ulceration

• Continue hourly sodium bicarbonate rinses
• Topical NSAID: Amlexanox 5% oral paste for localized ulcers 1
• If NSAIDs not tolerated: Acetaminophen as maintenance therapy 1
• Add immediate-release oral opioid or fast-acting fentanyl preparation (50 μg nasal spray) for breakthrough pain before meals 1

Important caveat: Fast-acting fentanyl is registered for opioid-tolerant patients but may be considered for short-term relief in this population 1

Step 3: Ulcerative Stomatitis Requiring Steroids

For multiple or difficult-to-reach ulcerations:

• Dexamethasone mouth rinse 0.1 mg/mL 1

For limited, easily accessible ulcers:

• Clobetasol gel or ointment 0.05% 1

Step 4: Refractory Ulcers

If no resolution with topical steroids:

• Intralesional triamcinolone injection weekly (total dose 28 mg)
• Continue topical clobetasol 0.05% 1
• Consult oral medicine specialist 1

Step 5: Severe/Highly Symptomatic or Recurrent Ulcers

For rapidly progressive symptoms or esophageal involvement:

• Systemic corticosteroids: Prednisone/prednisolone 30-60 mg (or 1 mg/kg) daily for 1 week
• Taper over second week 1

Pain Management Considerations

For persistent severe pain:

• Consider alternative administration routes (transdermal, intranasal) when oral intake is compromised 1
• Follow WHO pain management ladder 1
• Administer topical anesthetics before other mouthwashes if patient finds them painful 1

Etiology-Specific Management

Herpetic Stomatitis

• Antiviral medications (acyclovir, valacyclovir) started early can modify disease course 3
• Maintain fluid and electrolyte balance 3
• Combine with symptomatic measures above

Uremic Stomatitis

• Hemodialysis is primary treatment 4
• Analgesics and mouthwashes for symptom control 4
• Expect significant improvement after 7 hemodialysis sessions 4

Cancer Therapy-Associated

• Monitor for treatment modifications: 20-35% of patients require dose reduction, interruption, or discontinuation 6
• Early intervention prevents escalation and maintains treatment adherence 7, 2

Common Pitfalls

1. Physician awareness gap: 61.3% of physicians are unaware of published stomatitis management guidelines 6—familiarize yourself with ESMO/MASCC guidelines
2. Poor oral hygiene: Identified as the primary barrier to management (80.6%) 6—emphasize patient education
3. Delayed recognition: Symptoms peak 1-2 weeks post-chemotherapy 8—implement systematic oral assessments
4. Inadequate pain control: Oral pain significantly impacts quality of life—be aggressive with multimodal analgesia 2
5. Failure to escalate therapy: Don't persist with ineffective topical treatments when systemic steroids are indicated 1

Monitoring

• Frequency of assessment correlates with improvement 8
• Reinforce oral care protocols at each visit 8
• Document severity using standardized oral assessment tools 7
• Adjust cancer therapy dosing if stomatitis becomes dose-limiting 6

The evidence strongly supports a stepwise escalation approach, with the ESMO Clinical Practice Guidelines 1 providing the most comprehensive framework. While these are expert consensus recommendations, they represent the current standard of care for managing this common and potentially debilitating complication.